selected publications
- Placing purines in precision medicine: Targeting a metabolic reliance in KRAS-mutant tumors. iScience. 2026 Academic Article GET IT
- Unlocking the therapeutic potential of rigosertib as a selective therapy for ovarian cancer. Cell reports. Medicine. 2025 Academic Article GET IT
- Functional genomics pipeline identifies CRL4 inhibition for the treatment of ovarian cancer. Clinical and translational medicine. 2025 Academic Article GET IT
-
PI3King the Environment for Growth: PI3K Activation Drives Transcriptome Changes That Support Oncogenic Growth.
Cancer research.
2022
Editorial Article
GET IT
Times cited: 3 -
Circling back to PTEN: Fumarate inhibits canonical tumor suppressor.
Molecular cell.
2022
Article
GET IT
Times cited: 2 -
Patient-Derived In Vitro and In Vivo Models of Cancer.
Advances in experimental medicine and biology.
2022
Academic Article
GET IT
Times cited: 8